Healthcare provider profile · identity verified

Maher Saloum, MD

Internal Medicine · SAN ANTONIO, TX · NPI 1487650487

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	325	105
Rosuvastatin Calcium	Rosuvastatin Calcium	278	99
Metformin Hcl	Metformin Hcl	232	74
Montelukast Sodium	Montelukast Sodium	230	73
Losartan Potassium	Losartan Potassium	225	72
Levothyroxine Sodium	Levothyroxine Sodium	206	61
Lisinopril	Lisinopril	192	58
Pantoprazole Sodium	Pantoprazole Sodium	186	59
Amlodipine Besylate	Amlodipine Besylate	176	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	162	21
Hydrochlorothiazide	Hydrochlorothiazide	146	47
Gabapentin	Gabapentin	144	54
Albuterol Sulfate Hfa	Albuterol Sulfate	142	40
Furosemide	Furosemide	133	46
Prednisone	Prednisone	121	59
Tamsulosin Hcl	Tamsulosin Hcl	115	42
Fluticasone Propionate	Fluticasone Propionate	99	37
Escitalopram Oxalate	Escitalopram Oxalate	98	24
Trazodone Hcl	Trazodone Hcl	98	29
Jardiance	Empagliflozin	94	33
Glipizide	Glipizide	92	29
Carvedilol	Carvedilol	91	32
Vitamin D2	Ergocalciferol (Vitamin D2)	89	36
Famotidine	Famotidine	77	29
Meloxicam	Meloxicam	73	17
Duloxetine Hcl	Duloxetine Hcl	68	15
Omeprazole	Omeprazole	68	23
Simvastatin	Simvastatin	66	20
Tramadol Hcl	Tramadol Hcl	64	13
Potassium Chloride	Potassium Chloride	62	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	61	44
Trulicity	Dulaglutide	61	13
Metoprolol Succinate	Metoprolol Succinate	59	24
Azithromycin	Azithromycin	58	45
Pravastatin Sodium	Pravastatin Sodium	58	16
Mounjaro	Tirzepatide	57	11
Allopurinol	Allopurinol	55	21
Clopidogrel	Clopidogrel Bisulfate	55	19
Metoprolol Tartrate	Metoprolol Tartrate	51	21
Hydroxyzine Hcl	Hydroxyzine Hcl	50	20
Clotrimazole	Clotrimazole	49	14
Nifedipine Er	Nifedipine	47	14
Finasteride	Finasteride	46	18
Shingrix	Varicella-Zoster Ge/As01b/Pf	44	37
Pregabalin	Pregabalin	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	13
Ondansetron Hcl	Ondansetron Hcl	40	15
Alendronate Sodium	Alendronate Sodium	39	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	16
Levofloxacin	Levofloxacin	38	33
Buspirone Hcl	Buspirone Hcl	37	17
Acetaminophen-Codeine	Acetaminophen With Codeine	36	suppressed
Ozempic	Semaglutide	35	suppressed
Amoxicillin	Amoxicillin	33	26
Primidone	Primidone	33	suppressed
Tresiba Flextouch U-200	Insulin Degludec	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	11
Eliquis	Apixaban	32	13
Farxiga	Dapagliflozin Propanediol	32	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	30	30
Ibuprofen	Ibuprofen	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Baclofen	Baclofen	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	16
Hydralazine Hcl	Hydralazine Hcl	28	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Ondansetron Odt	Ondansetron	27	13
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Metronidazole	Metronidazole	25	24
Januvia	Sitagliptin Phosphate	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Fluconazole	Fluconazole	20	14
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Clonidine	Clonidine	18	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	18	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	15
Humalog Kwikpen U-200	Insulin Lispro	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Cilostazol	Cilostazol	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Incontrol Pen Needle	Pen Needle, Diabetic	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Bydureon Bcise	Exenatide Microspheres	14	suppressed
Dexamethasone	Dexamethasone	14	14
Estradiol	Estradiol	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Sertraline Hcl	Sertraline Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Dexmethylphenidate Hcl Er	Dexmethylphenidate Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Diazepam	Diazepam	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Ofloxacin	Ofloxacin	11	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error